Ping Shek will work on key M&A accounts in healthcare
Corporate advisory firm PharmaVentures, based in Oxford, UK, has appointed Ping Shek as senior director in the Transactions division of Corporate Advisory. He will work on key M&A and divestment accounts in the healthcare business sector.
Shek is a physics graduate from Oxford and has an MBA from the London Business School. He has previously worked with investment bankers Morgan Stanley International, Lazard Brothers, JP Morgan, Monitor Group and the Anglo Chinese Group.
Commenting on the appointment, Fintan Walton, PharmaVentures’ chief executive, said: ‘Our Transactions division is currently working with a number of key companies in the life sciences sector, providing a comprehensive M&A and asset divestment service and has recently celebrated successes for a number of clients including UCB, Sanofi, Helsinn and Dow Chemical. Our client portfolio will benefit from this key appointment to the team.’